Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators

dc.creatorRuiz, María Sol
dc.creatorMedina, M.
dc.creatorTapia, I.
dc.creatorMordoh, Jose
dc.creatorCross, N. C. P.
dc.creatorLarripa, Irene Beatriz
dc.creatorBianchini, Michele
dc.date.accessioned2018-05-13T18:21:52Z
dc.date.accessioned2018-11-06T13:38:56Z
dc.date.available2018-05-13T18:21:52Z
dc.date.available2018-11-06T13:38:56Z
dc.date.created2018-05-13T18:21:52Z
dc.date.issued2016-12
dc.identifierRuiz, María Sol; Medina, M.; Tapia, I.; Mordoh, Jose; Cross, N. C. P.; et al.; Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators; Nature Publishing Group; Leukemia; 30; 11; 12-2016; 2258-2260
dc.identifier0887-6924
dc.identifierhttp://hdl.handle.net/11336/45027
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1877750
dc.description.abstractResidual disease in chronic myeloid leukemia (CML) patients undergoing therapy with tyrosine kinase inhibitors (TKIs) is measured by assessing the quantity of transcripts of the BCR-ABL1 fusion gene in peripheral white blood cells. This analysis is based on reverse-transcription quantitative PCR (RT–qPCR) technology; however, the wide array of methods used worldwide has led to large variation in quantitative BCR-ABL1 measurements, which hamper inter-laboratory comparative studies
dc.languageeng
dc.publisherNature Publishing Group
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/leu2016197
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1038/leu.2016.197
dc.relationinfo:eu-repo/semantics/altIdentifier/pmid/27451977
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectLMC
dc.subjectBCR-ABL1
dc.subjectFUSION PROTEINS
dc.subjectLEUKEMIA
dc.titleStandardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución